Hormone Therapy Doesn't Appear to Protect Against Alzheimer's

This article originally appeared here.
Share this content:
Hormone Therapy Doesn't Appear to Protect Against Alzheimer's
Hormone Therapy Doesn't Appear to Protect Against Alzheimer's

THURSDAY, Feb. 16, 2017 (HealthDay News) -- Women who use hormone therapy (HT) after menopause may not have a lower risk of developing Alzheimer's disease (AD), although there is some evidence that long-term use -- over a decade -- might be tied to a lower risk, according to a study published online Feb. 15 in Neurology.

The new findings are based on 8,195 Finnish women who were between the ages of 47 and 56 when the study began in 1989. At that point, and then every few years, they reported on their hormone use. Then in 1995, that information became available in a national prescription registry. The researchers used it to verify the women's reports.

Over 20 years of follow-up, 227 women were diagnosed with AD. In general, the researchers found no correlation between women's hormone use and their risk of AD. However, women who said they'd used HT for more than 10 years were half as likely to develop AD as nonusers were. Yet, when the researchers looked at the data from the prescription registry -- not women's reports -- there was no evidence that long-term HT was tied to a lower AD risk.

"Our results do not provide strong evidence for a protective association between postmenopausal HT use and AD or dementia," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »